The Institute of Cancer Research
@icr.ac.uk
The ICR is making the discoveries that defeat cancer.
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
Giles Turner, 65, was diagnosed with aggressive prostate cancer in March 2023. Following treatment – including with the drug abiraterone, which was discovered and developed by our scientists – he is now in remission. Read Giles’ story here: www.icr.ac.uk/research-and...
January 9, 2026 at 10:01 AM
Giles Turner, 65, was diagnosed with aggressive prostate cancer in March 2023. Following treatment – including with the drug abiraterone, which was discovered and developed by our scientists – he is now in remission. Read Giles’ story here: www.icr.ac.uk/research-and...
This research represents a big step toward smarter, more precise therapies that could help treat cancers that resist current drugs and allow more patients to live longer, better lives.
Read more about the research here: www.icr.ac.uk/about-us/icr...
Read more about the research here: www.icr.ac.uk/about-us/icr...
January 8, 2026 at 10:31 AM
This research represents a big step toward smarter, more precise therapies that could help treat cancers that resist current drugs and allow more patients to live longer, better lives.
Read more about the research here: www.icr.ac.uk/about-us/icr...
Read more about the research here: www.icr.ac.uk/about-us/icr...
Great to see our new ICR-St Mark's 'Boomers Project' featured on BBC News!
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
January 7, 2026 at 12:09 PM
Great to see our new ICR-St Mark's 'Boomers Project' featured on BBC News!
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
Professor Paul Workman, former Chief Executive of the ICR, has been awarded an OBE in the 2026 New Year Honours for his incredible impact on cancer research worldwide.
👏 Huge Congratulations, Professor Workman!
👏 Huge Congratulations, Professor Workman!
December 30, 2025 at 7:55 AM
Professor Paul Workman, former Chief Executive of the ICR, has been awarded an OBE in the 2026 New Year Honours for his incredible impact on cancer research worldwide.
👏 Huge Congratulations, Professor Workman!
👏 Huge Congratulations, Professor Workman!
🎉Season's greetings and Happy New Year from the ICR! 🎇
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
December 24, 2025 at 9:54 AM
🎉Season's greetings and Happy New Year from the ICR! 🎇
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
If you are a clinical professional looking to understand more about image-guided and adaptive radiotherapy techniques, sign up for our 2-day course today. The closing date to register is Monday 12 January 2026.
Find out more ➡️ www.icr.ac.uk/study-and-ca...
Find out more ➡️ www.icr.ac.uk/study-and-ca...
December 19, 2025 at 10:29 AM
If you are a clinical professional looking to understand more about image-guided and adaptive radiotherapy techniques, sign up for our 2-day course today. The closing date to register is Monday 12 January 2026.
Find out more ➡️ www.icr.ac.uk/study-and-ca...
Find out more ➡️ www.icr.ac.uk/study-and-ca...
A recent study has revealed why some #myeloma drugs stop working – and why newer ones can still succeed.
🧵 Read our thread to find out more ⤵️
🧵 Read our thread to find out more ⤵️
December 17, 2025 at 8:04 AM
A recent study has revealed why some #myeloma drugs stop working – and why newer ones can still succeed.
🧵 Read our thread to find out more ⤵️
🧵 Read our thread to find out more ⤵️
Would you like to be involved in a video about radiotherapy trials?
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
December 15, 2025 at 2:28 PM
Would you like to be involved in a video about radiotherapy trials?
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
📺TONIGHT: Don't miss 'Cancer Detectives: Finding the Cures' at 9pm on Channel 4.
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
November 27, 2025 at 8:40 PM
📺TONIGHT: Don't miss 'Cancer Detectives: Finding the Cures' at 9pm on Channel 4.
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
Last week, we welcomed 72 sixth form students from seven local schools to Sutton for our annual Careers in Research Evening. 👋
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
November 27, 2025 at 2:03 PM
Last week, we welcomed 72 sixth form students from seven local schools to Sutton for our annual Careers in Research Evening. 👋
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
They explored our biology and chemistry labs, joined hands-on demos, and spoke with researchers, students and clinical colleagues about routes into science and healthcare.
🚨BIG news 🚨
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
November 25, 2025 at 7:02 PM
🚨BIG news 🚨
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
The ICR has received the Queen Elizabeth Prize for Higher and Further Education for our groundbreaking radiotherapy research.
This work has improved cancer care worldwide—through advanced techniques, landmark trials, and training the next generation of oncologists.
#QEdPrizes
📢 Ahead of the Budget next week, we've published a paper calling for the Government to both invest in and reform the Charity Research Support Fund (CRSF) – a critical funding stream that enables vital charity-funded research in universities.
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
November 20, 2025 at 10:15 AM
📢 Ahead of the Budget next week, we've published a paper calling for the Government to both invest in and reform the Charity Research Support Fund (CRSF) – a critical funding stream that enables vital charity-funded research in universities.
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
Read our paper (PDF download) ⤵️
ICR.ac.uk/CRSF
November 14, 2025 at 1:27 PM
to being the first internationally to treat prostate cancer patients with a new, more precise form of radiotherapy in 2000, and recently showing that a simple at-home spit test is more accurate at identifying future risk of prostate cancer for some men.
November 14, 2025 at 1:27 PM
to being the first internationally to treat prostate cancer patients with a new, more precise form of radiotherapy in 2000, and recently showing that a simple at-home spit test is more accurate at identifying future risk of prostate cancer for some men.
🚨 Our scientists have been at the forefront of #ProstateCancer screening and drug development for decades – leading innovative research and international clinical trials to give every man with prostate cancer the best chance of survival with a better quality of life.
🧵⬇️
🧵⬇️
November 14, 2025 at 1:27 PM
🚨 Our scientists have been at the forefront of #ProstateCancer screening and drug development for decades – leading innovative research and international clinical trials to give every man with prostate cancer the best chance of survival with a better quality of life.
🧵⬇️
🧵⬇️
Our new blog takes you behind the scenes of that milestone – exploring how the centre came to be, the discoveries that have defined its first 25 years and the researchers driving progress for the future.
November 13, 2025 at 2:25 PM
Our new blog takes you behind the scenes of that milestone – exploring how the centre came to be, the discoveries that have defined its first 25 years and the researchers driving progress for the future.
It's 25 years of the @breastcancernow.bsky.social Toby Robins Research Centre at the ICR, celebrating the pioneering research that’s transforming the outlook for people with #BreastCancer 🩷
November 13, 2025 at 2:25 PM
It's 25 years of the @breastcancernow.bsky.social Toby Robins Research Centre at the ICR, celebrating the pioneering research that’s transforming the outlook for people with #BreastCancer 🩷
By ruling out a previously plausible explanation, the research helps focus efforts on more promising areas – from drug metabolism to immune responses – and highlights the importance of considering sex as a biological variable in future AML research and clinical trial design.
November 11, 2025 at 10:24 AM
By ruling out a previously plausible explanation, the research helps focus efforts on more promising areas – from drug metabolism to immune responses – and highlights the importance of considering sex as a biological variable in future AML research and clinical trial design.
Graduation Day is here! 🎓🎓🎓
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
October 27, 2025 at 4:43 PM
Graduation Day is here! 🎓🎓🎓
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
A huge congratulations to our graduates, ICR fellows, and ICR associates!
Today, we celebrate you and your hard work, dedication, and passion for cancer research.
We’re so incredibly proud of you ✨✨✨✨
Thank you for being such a special part of our community ❤️
“Although drug resistance closes some doors, it can open new ones.”
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
October 23, 2025 at 9:34 AM
“Although drug resistance closes some doors, it can open new ones.”
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
In exciting research, our scientists have found that a recently discovered vulnerability in soft tissue sarcomas could pave the way for smarter, more adaptive treatment strategies that extend and save more lives.
At the ICR, statisticians such as PhD student Emily Alger, @mle-alger.bsky.social are building on those methods to design smarter, more patient-centred clinical trials – ensuring that data leads to better decisions and better outcomes for patients.
October 20, 2025 at 9:21 AM
At the ICR, statisticians such as PhD student Emily Alger, @mle-alger.bsky.social are building on those methods to design smarter, more patient-centred clinical trials – ensuring that data leads to better decisions and better outcomes for patients.
Men with BRCA1 and BRCA2 mutations should get annual #ProstateCancer screening.
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
October 17, 2025 at 8:05 AM
Men with BRCA1 and BRCA2 mutations should get annual #ProstateCancer screening.
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
The IMPACT trial finds BRCA1 carriers are 3 times more likely to have aggressive prostate cancers than non-carriers.
Results from the international trial shared at @myesmo.bsky.social
www.icr.ac.uk/about-us/icr...
We were thrilled to welcome @andrewranger-mp.bsky.social and Lesley Griffiths MS to the Wrexham #TerryFox Run! 🏃
It is fantastic to have support from Parliament and the Senedd for a brilliant event honouring Terry’s legacy whilst also raising vital funds for our life-changing cancer research.
It is fantastic to have support from Parliament and the Senedd for a brilliant event honouring Terry’s legacy whilst also raising vital funds for our life-changing cancer research.
October 9, 2025 at 10:28 AM
We were thrilled to welcome @andrewranger-mp.bsky.social and Lesley Griffiths MS to the Wrexham #TerryFox Run! 🏃
It is fantastic to have support from Parliament and the Senedd for a brilliant event honouring Terry’s legacy whilst also raising vital funds for our life-changing cancer research.
It is fantastic to have support from Parliament and the Senedd for a brilliant event honouring Terry’s legacy whilst also raising vital funds for our life-changing cancer research.
🔬 A new study, led by @udaibanerji.bsky.social, reveals a fast, low-cost solution for harvesting #organoids.
These miniature 3D models of human tissue mimic the behaviour of real tumours and are considered the future of #CancerResearch.
Read more in our 🧵⤵️
#Oncology
These miniature 3D models of human tissue mimic the behaviour of real tumours and are considered the future of #CancerResearch.
Read more in our 🧵⤵️
#Oncology
October 1, 2025 at 9:13 AM
🔬 A new study, led by @udaibanerji.bsky.social, reveals a fast, low-cost solution for harvesting #organoids.
These miniature 3D models of human tissue mimic the behaviour of real tumours and are considered the future of #CancerResearch.
Read more in our 🧵⤵️
#Oncology
These miniature 3D models of human tissue mimic the behaviour of real tumours and are considered the future of #CancerResearch.
Read more in our 🧵⤵️
#Oncology
🚨 Big news from the TORPEdO trial
IMRT is just as effective as proton beam therapy for most head and neck cancer patients.
That means more people can access the best treatment locally—without needing specialist centres.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
IMRT is just as effective as proton beam therapy for most head and neck cancer patients.
That means more people can access the best treatment locally—without needing specialist centres.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
September 29, 2025 at 6:11 PM
🚨 Big news from the TORPEdO trial
IMRT is just as effective as proton beam therapy for most head and neck cancer patients.
That means more people can access the best treatment locally—without needing specialist centres.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...
IMRT is just as effective as proton beam therapy for most head and neck cancer patients.
That means more people can access the best treatment locally—without needing specialist centres.
Learn more here ⬇️
www.icr.ac.uk/about-us/icr...